Pink Sheet Podcast: Trump Picks Robert F. Kennedy Jr. To Lead HHS, How Could He Disrupt FDA?

 
• By Derrick Gingery, Sarah Karlin-Smith, Nielsen Hobbs, and Michael McCaughan

Pink Sheet reporter and editors, and guest Michael McCaughan of Prevision Policy, continue the discussion of Donald Trump’s potential impact on the FDA, including how Robert F. Kennedy Jr. could change the agency as head of HHS, and FDA Commissioner Robert Califf’s request that industry help preserve the agency status quo.

Pink Sheet podcast
FDA staffing and other changes are possible if Robert F. Kennedy Jr. becomes HHS Secretary. • Source: Citeline/Shutterstock
Michael McCaughan

Read more by Michael McCaughan

Michael McCaughan is a founding member of Prevision Policy LLC, a leading provider of regulatory and reimbursement policy analysis for the biopharma industry. He was previously the Editor-In-Chief of The Pink Sheet and remains a contributor to the publication.

More from Elections

More from Podcasts